pharm edaily

[NA Eun-kyung, Edaily Reporter] MicroDigital announced Sunday that it has formed a strategic alliance with Parker Hannifin, a global leader in industrial components, to enter the North American market for single-use cell culture systems, an industry estimated at 7 trillion won (approximately $4.8 billion).

OrbTec™

Under the partnership, MicroDigital’s single-use cell culture systems will be sold under the Parker Hannifin brand through a private-label agreement. The product was officially launched at INTERPHEX New York 2025, the world’s largest trade show for bioprocess equipment and technologies.

Parker Hannifin’s newly introduced product, OrbTec™, incorporates MicroDigital’s proprietary Orbital & Rocking Technology, and is being recognized as a next-generation solution that surpasses conventional systems.

The launch marks more than a product debut ― it signals Parker Hannifin’s full-scale entry into the single-use bioreactor market. The company plans to aggressively expand its bioprocessing business following this release.

With this partnership, MicroDigital has established a foundation for the continued supply of single-use bioreactors and disposable bags in the U.S. market.

“This exhibition marks the starting point of our official business partnership with Parker Hannifin,” said Kyung-Nam Kim, CEO of MicroDigital. “We aim to lead innovation in North America by combining our proprietary technology with Parker’s global reach.”

MicroDigital said it will accelerate its push into the North American market and further strengthen its presence in the global bioprocess equipment sector through the collaboration.